PKA phosphorylation and 14-3-3 interaction regulate the function of neurofibromatosis type I tumor suppressor, neurofibromin

被引:49
作者
Feng, LP
Yunoue, SJ
Tokuo, H
Ozawa, T
Zhang, DW
Patrakitkomjorn, S
Ichimura, T
Saya, H
Araki, N
机构
[1] Kumamoto Univ, Grad Sch Med Sci, Dept Tumor Genet & Biol, Kumamoto 8608556, Japan
[2] Tokyo Metropolitan Univ, Grad Sch Sci, Dept Chem, Hachioji, Tokyo 1920397, Japan
来源
FEBS LETTERS | 2004年 / 557卷 / 1-3期
基金
日本学术振兴会;
关键词
neurofibromatosis type I; neurofibromin; cAMP-dependent protein kinase; tumor suppressor; 14-3-3; protein; GTPase activating protein;
D O I
10.1016/S0014-5793(03)01507-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neurofibromin, a neurofibromatosis type I (NF1) tumor suppressor gene product, has a domain acting as a GTPase activating protein and functions in part as a negative regulator of Ras. Loss of neurofibromin expression in NF1 patients is associated with elevated Ras activity and increased cell proliferation. Therefore, regulation of the function of neurofibromin is heavily involved in cell growth and differentiation. In the present study, we identified a novel cellular neurofibromin-associating protein, 14-3-3, which belongs to a highly conserved family of proteins that regulate intracellular signal transduction events in all eukaryotic cells. The interaction of 14-3-3 is mainly directed to the C-terminal domain (CTD) of neurofibromin, and the cAMP-dependent protein kinase (PKA)-dependent phosphorylation clustered on CTD-Ser (2576, 2578, 2580, 2813) and Thr (2556) is required for the interaction. Interestingly, the increased phosphorylation and association of 14-3-3 negatively regulate the function of neurofibromin. These findings indicate that PKA phosphorylation followed by 14-3-3 protein interaction may modulate the biochemical and biological functions of neurofibromin. (C) 2003 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.
引用
收藏
页码:275 / 282
页数:8
相关论文
共 19 条
[1]   PROTEINS REGULATING RAS AND ITS RELATIVES [J].
BOGUSKI, MS ;
MCCORMICK, F .
NATURE, 1993, 366 (6456) :643-654
[2]   Neurofibromatosis 1: closing the GAP between mice and men [J].
Dasgupta, B ;
Gutmann, DH .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2003, 13 (01) :20-27
[3]  
DUCATMAN BS, 1984, J NEURO-ONCOL, V2, P241
[4]   Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the CAP-related domain [J].
Fahsold, R ;
Hoffmeyer, S ;
Mischung, C ;
Gille, C ;
Ehlers, C ;
Kücükceylan, N ;
Abdel-Nour, M ;
Gewies, A ;
Peters, H ;
Kaufmann, D ;
Buske, A ;
Tinschert, S ;
Nürnberg, P .
AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 66 (03) :790-818
[5]   14-3-3 proteins: Structure, function, and regulation [J].
Fu, HA ;
Subramanian, RR ;
Masters, SC .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2000, 40 :617-647
[6]   Septin ring assembly involves cycles of GTP loading and hydrolysis by Cdc42p [J].
Gladfelter, AS ;
Bose, I ;
Zyla, TR ;
Bardes, ESG ;
Lew, DJ .
JOURNAL OF CELL BIOLOGY, 2002, 156 (02) :315-326
[7]   A neurofibromatosis-1-regulated pathway is required for learning in Drosophila [J].
Guo, HF ;
Tong, JY ;
Hannan, F ;
Luo, L ;
Zhong, Y .
NATURE, 2000, 403 (6772) :895-898
[8]   IDENTIFICATION OF THE SITE OF INTERACTION OF THE 14-3-3-PROTEIN WITH PHOSPHORYLATED TRYPTOPHAN-HYDROXYLASE [J].
ICHIMURA, T ;
UCHIYAMA, J ;
KUNIHIRO, O ;
ITO, M ;
HORIGOME, T ;
OMATA, S ;
SHINKAI, F ;
KAJI, H ;
ISOBE, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (48) :28515-28518
[9]   Phosphorylation of neurofibromatosis type 1 gene product (neurofibromin) by cAMP-dependent protein kinase [J].
Izawa, I ;
Tamaki, N ;
Saya, H .
FEBS LETTERS, 1996, 382 (1-2) :53-59
[10]   Fluorescently labelled guanine nucleotide binding proteins to analyse elementary steps of GAP-catalysed reactions [J].
Kraemer, A ;
Brinkmann, T ;
Plettner, I ;
Goody, R ;
Wittinghofer, A .
JOURNAL OF MOLECULAR BIOLOGY, 2002, 324 (04) :763-774